Latest news for Opthea (OTC:CKDXF) Stock

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

Opthea Ltd

Opthea Limited (AU:OPT) has released an update. Opthea Limited has successfully completed a significant capital raise of A$171.5 million through an...

Opthea Limited Raises A$171.5 Million in Capital

Opthea Limited (AU:OPT) has released an update. Opthea Limited has launched a fully underwritten Retail Entitlement Offer to raise approximately A$...

Opthea Limited Launches Major Retail Offering

Opthea Limited (AU:OPT) has released an update. Opthea Limited has announced a new application for the quotation of 428,658,137 ordinary fully paid...

Opthea Limited Seeks Quotation for New Securities

Opthea Limited (AU:OPT) has released an update. Opthea Limited has experienced a change in the substantial holding by Regal Funds Management Pty Li...

Opthea Limited Reports Change in Major Holdings

Opthea Limited (AU:OPT) has released an update. Opthea Limited has successfully completed a significant capital raise of approximately A$227.3 mill...

Opthea Concludes Major Capital Raising Effort

Opthea Limited (AU:OPT) has released an update. Opthea Limited has announced the application for quotation of a substantial number of securities on...

Opthea Limited Expands Market Presence

Opthea Limited (AU:OPT) has released an update. Opthea Limited has released a snapshot of its top shareholders, with UBS Nominees Pty Ltd leading t...

Opthea Limited Top Shareholders Revealed

Opthea Limited (AU:OPT) has released an update. Opthea Limited has experienced a shift in its substantial holdings, with The Bank of New York Mello...

Opthea Sees Significant Holder's Voting Power Dip

Opthea Limited (AU:OPT) has released an update. Opthea Limited has announced a change in substantial shareholdings, with Regal Funds Management Pty...

Opthea Limited Reports Major Shareholding Changes

In a report released today, Thomas Wakim from Bell Potter maintained a Buy rating on Opthea Limited (CKDXF – Research Report), with a price target ...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Opthea

News

Latest news for Opthea (OTC:CKDXF) Stock